Carcinoma endometrii
Showing 1 - 25 of 7,589
Endometrial Carcinoma Cellular Diagnosis Trial (1.hysterectomy with bilateral oophorectomy and pelvic lymphonodectomy. 2
Completed
- Endometrial Carcinoma Cellular Diagnosis
- 1.hysterectomy with bilateral oophorectomy and pelvic lymphonodectomy. 2 explorative curettage
- (no location specified)
Jul 16, 2023
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)
Recruiting
- Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
May 24, 2023
Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Basal Cell Carcinoma of Skin
- microscopy confocal (Histolog Scanner)
-
Vandœuvre-lès-Nancy, FranceGilles Dolivet
Jul 7, 2023
Urologic Cancer Trial in Taipei
Recruiting
- Urologic Cancer
-
Taipei, TaiwanYu wei-lan
Feb 2, 2023
The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,
Recruiting
- The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
- Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
-
Hanzhou, Zhejiang, ChinaLulu Liu
Jul 14, 2023
Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- PVE+cTACE+Camrelizumab+Apatinib
- cTACE+Atirizumab+Bevacizumab
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023
Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)
Not yet recruiting
- Endometrial Carcinoma
- Tumor Molecular Features Screening Model
- open surgery
- laparoscopic surgery
- (no location specified)
Jun 7, 2023
Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Carrilizumab with albumin-binding paclitaxel
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 23, 2023
Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)
Not yet recruiting
- Nasopharyngeal Carcinoma
- KSD-101
-
Wuhan, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023
Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Recruiting
- Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
- Radiotherapy
- Toripalimab
- (no location specified)
Mar 17, 2023
Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
-
Qingdao, Shandong, China
- +1 more
Nov 13, 2023
Simultaneous CLE Guided Crybiopsy in Pulmonary Nodules
Recruiting
- Pulmonary Disease
- CLE-guided cryobiopsy
-
Vienna, AustriaMedical University of Vienna
Sep 20, 2023
Key Genes in Hepatocellular Carcinoma
Recruiting
- Hepatocellular Carcinoma
- None of intervention
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023
Single-cell RNA Sequencing Resolves Regulatory Role of HBV on
Recruiting
- HBV
- Primary Liver Cancer
- HBV DNA Sequencing
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 22, 2022
Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Not yet recruiting
- Nasopharyngeal Carcinoma
- Tongue image
-
Zhuhai, ChinaThe Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023
Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 25, 2023
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
Not yet recruiting
- Squamous Cell Carcinoma
-
San Francisco, CaliforniaPower Life Sciences
Jun 23, 2023
Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)
Recruiting
- Hepatocellular Carcinoma
-
Seoul, Korea, Republic ofAsan Medical Center
Nov 14, 2023
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Immunotherapy in Upper Tract Urothelial Carcinoma
Not yet recruiting
- Urothelial Carcinoma
- Evaluation of anti-PD-(L)1 immunotherapy efficacy
- (no location specified)
Oct 27, 2023
Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- +10 more
-
Aurora, Colorado
- +6 more
Jan 4, 2023
Hepatocellular Carcinoma Trial in Yerevan
Recruiting
- Hepatocellular Carcinoma
-
Yerevan, ArmeniaNikomed Medical Center
Jun 28, 2023